FDA approves Lutathera for pediatric GEP-NET patients 12 and olderNov 6Regulatory decisionlutetium lu 177 dotatateNovartis
Lantheus reports Q3 2026 results, gains two approvals amid pending Curium mergerNov 5Quarterly updateflorquinitau f-18Lantheus Holdings, Inc.
Sign inSign in